CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients (Q37349172)
Jump to navigation
Jump to search
scientific article published on September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients |
scientific article published on September 2008 |
Statements
1 reference
CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients (English)
1 reference
Marjorie Bosche
1 reference
Joseph W Adelsberger
1 reference
Sarah W Read
1 reference
Michele Di Mascio
1 reference
Sharat Srinivasula
1 reference
Rosanne Burke
1 reference
William Sachau
1 reference
Richard T Davey
1 reference
Jorge A Tavel
1 reference
Chiung-Yu Huang
1 reference
Haleem J Issaq
1 reference
Stephen D Fox
1 reference
H Clifford Lane
1 reference
Joseph A Kovacs
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference